Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

Biotechnology

Healthcare
$4.16 -0.81%

-$0.01 today

Market cap
$55.18M
Beta
2.34
P/E (TTM)
-0.6
EPS (TTM)
-$1.42
52W Low $0.38High $2.45

Volume 0.10M

Average 2.07M

GUTS Tax Payables

Taxes owed to authorities that have not yet been paid.

Fractyl Health, Inc. Common StockNASDAQ: GUTS

Tax Payables · Q1 FY2026 · quarter ended Mar 2026

Tax payables remains negative

Q1 FY2026 tax payables was $0, compared with $0 a year earlier.

Context

  • Tax payables amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Tax payables increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Payables history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Tax Payables vs competitors

How GUTS compares with its peers on the latest reported figures

  • GUTS's Mar 2026 tax payables of $0 is the highest of the 7 companies compared; the peer median is $0.
  • Tax payables amounts to 0.0% of total assets for GUTS, versus a peer median of 0.0%.
GUTS Competitors Peer median
Tax Payables for GUTS and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GUTSFractyl Health, Inc. Common StockMar 2026$0 ——0.0%
ARTVArtiva Biotherapeutics, Inc.Mar 2026$0 ——0.0%
ALXOALX Oncology Holdings Inc.Mar 2026$0 ——0.0%
STROSutro Biopharma, Inc.Mar 2026$0 ——0.0%
BMEABiomea Fusion, Inc.Mar 2026$0 ——0.0%
DTILPrecision BioSciences, Inc.Mar 2026$0 ——0.0%
ATYRaTyr Pharma, Inc.Mar 2026$0 ——0.0%
Peer median (excluding GUTS) $0——0.0%

Competitors are the stored peer set for GUTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents95.47M49.27M33.52M67.46M81.54M
Short-term Investments00000
Net Receivables0022K00
Inventory0073K73K0
Other Current Assets915K2.36M2.03M4.23M6.04M
Total Current Assets96.39M51.63M35.65M71.76M87.58M
Property, Plant & Equipment (Net)1.35M1.65M30.77M31.39M29.23M
Goodwill00000
Intangible Assets0863K835K00
Long-term Investments04.26M4.26M4.26M4.26M
Tax Assets00000
Other Non-current Assets4.82M2.56M4.7M666K337K
Total Non-current Assets6.16M9.33M40.56M36.31M33.83M
Total Assets102.55M60.96M76.21M108.08M121.4M
Account Payables970K980K553K3.24M1.57M
Short-term Debt15.72M02.73M05.1M
Tax Payables00000
Deferred Revenue(970K)(980K)000
Other Current Liabilities5.13M3.3M4.4M7.4M6M
Total Current Liabilities23.65M7.31M11.19M19.78M18.33M
Long-term Debt287.33M305.09M342.48M30.16M30.59M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities555K409K19.1M2.33M37.07M
Total Non-current Liabilities288.22M305.96M390.09M59.88M93.62M
Total Liabilities311.87M313.28M401.27M79.65M111.94M
Common Stock00001K
Retained Earnings(223.07M)(269.53M)(346.62M)(415.31M)(556.26M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(209.33M)(252.32M)(325.06M)28.42M9.46M
Total Debt304.34M306.81M373.72M62.5M61.65M
Net Debt208.87M257.54M340.2M(4.96M)(19.89M)

Fractyl Health, Inc. Common Stock

NASDAQ:GUTS

Intrinsic Alpha fair value

Locked

Current Price

$4.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.